Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Ipsen reports CHMP negative review for use of palovarotene in EU

January 27, 2023 Research and Development

Ipsen, a biopharmaceutical company focused on medicines in oncology, rare diseases and neuroscience, have been denied marketing authorisation by the …
News

IsoChemiX develop molecules to speed up R&D process

January 27, 2023 Research and Development

UK-based pharmaceutical drug discovery company IsoChemiX is developing molecules which will have the ability to cut both the time and …
News

AI finds liver cancer drug candidate in only 30 days

January 26, 2023 Research and Development

With most drug discovery and development processes taking years, if not decades, a team of scientists have broken records with …
News

Poxel given EC’s Orphan Drug Designation for rare metabolic disorders

January 25, 2023 Research and Development

Clinical stage biopharmaceutical company Poxel, who focus on developing innovative treatments for chronic, serious diseases with metabolic pathophysiology, has been …
News

TheracosBio’s oral drug approved by FDA for adults with type 2 diabetes

January 24, 2023 Research and Development

TheracosBio has announced that the first oral SGLT2 inhibitor, bexaflilozin, has been approved by the FDA for the treatment of …
News

FDA grants Accelerated Approval for Seagen’s colorectal cancer treatment

January 23, 2023 Research and Development

Seagen Inc has been given FDA Accelerated Approval for its colorectal drug TUKYSA (tucatinib) after reviewing positive data from the …
News

AI and motion capture technology used to monitor movement disorders

January 23, 2023 Research and Development

A team of researchers have been developing a monitoring system to assess the progression of movement disorders. The new technology …
News

FDA rejects accelerated approval for Eli Lilly’s Alzheimer’s drug, donanemab

January 20, 2023 Research and Development

Eli Lilly has announced that its accelerated approval bid for Alzheimer’s disease drug, donanemab, has been rejected by the FDA. …
News

Genentech announce positive results from phase 3 IMbrave050 study

January 19, 2023 Research and Development

Genentech, based in California, US, has announced positive results from its phase 3 IMbrave050 trial, after the study met its …
News

Moderna’s mRNA vaccine appears promising for older adults with RSV

January 19, 2023 Research and Development

Moderna’s respiratory syncytial virus (RSV) vaccine has demonstrated positive levels of efficacy in older adults throughout a phase 3 trial. …
News

Neuronetics Inc. announces efficacy of treatment for neurohealth disorders

January 18, 2023 Research and Development

US-based commercial-stage medical technology company Neuronetics Inc., which focuses on designing, developing and marketing products that improve the quality of …
News

Shockwave Medical acquires Neovasc for $100m

January 18, 2023 Research and Development

US-based cardiovascular medical device company Shockwave Medical has signed a deal to acquire specialty medical device company Neovasc for around …
News

Luye Pharma’s Rykindo® approved by FDA for treatment of schizophrenia and bipolar 1 disorder

January 16, 2023 Research and Development

International pharmaceutical company, Luye Pharma, has announced that Rykindo® has received FDA approval for the treatment of schizophrenia in adult …
News

AstraZeneca’s Tezspire gains CHMP approval for the treatment of severe asthma

January 16, 2023 Research and Development

AstraZeneca has announced that Tezspire (also known as tezepelumab) has received approval from the EMA’s Committee for Medicinal Products for …
News

First patient enrolled in Inari DEFIANCE trial for deep vein thrombosis

January 13, 2023 Research and Development

Inari Medical has announced that the first patient has been enrolled in the DEFIANCE trial. This trial will evaluate the …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025